Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

BSX

Boston Scientific Corp

Dec 11 • 10:12AM ET

92.95

+0.25 0.27 %

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO SPY IVV VUG XLV IHI VHT IVW IWD

Index	S&P 500	P/E	49.71	EPS (ttm)	1.87	Insider Own	0.39%	Shs Outstand	1.48B	Perf Week	-4.88%
Market Cap	137.79B	Forward P/E	26.79	EPS next Y	3.47	Insider Trans	-5.20%	Shs Float	1.48B	Perf Month	-9.32%
Enterprise Value	148.70B	PEG	1.66	EPS next Q	0.78	Inst Own	93.40%	Short Float	1.27%	Perf Quarter	-9.50%
Income	2.79B	P/S	7.12	EPS this Y	20.95%	Inst Trans	0.57%	Short Ratio	1.90	Perf Half Y	-5.69%
Sales	19.35B	P/B	5.89	EPS next Y	14.30%	ROA	6.91%	Short Interest	18.73M	Perf YTD	4.06%
Book/sh	15.78	P/C	100.36	EPS next 5Y	16.16%	ROE	12.66%	52W High	109.50 -15.11%	Perf Year	4.77%
Cash/sh	0.93	P/FCF	36.03	EPS past 3/5Y	21.99% -17.84%	ROIC	7.99%	52W Low	85.98 8.11%	Perf 3Y	105.82%
Dividend Est.	-	EV/EBITDA	30.99	Sales past 3/5Y	12.10% 9.30%	Gross Margin	62.57%	Volatility	2.64% 2.23%	Perf 5Y	170.12%
Dividend TTM	-	EV/Sales	7.68	EPS Y/Y TTM	54.80%	Oper. Margin	17.82%	ATR (14)	2.16	Perf 10Y	415.24%
Dividend Ex-Date	-	Quick Ratio	0.96	Sales Y/Y TTM	21.62%	Profit Margin	14.43%	RSI (14)	32.68	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	1.51	EPS Q/Q	60.10%	SMA20	-5.49%	Beta	0.67	Target Price	127.03
Payout	0.00%	Debt/Eq	0.51	Sales Q/Q	20.34%	SMA50	-6.00%	Rel Volume	0.51	Prev Close	92.70
Employees	53000	LT Debt/Eq	0.49	Earnings	Oct 22 BMO	SMA200	-8.19%	Avg Volume	9.87M	Price	92.95
IPO	May 19, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.09% 1.93%	Trades		Volume	769,433	Change	0.27%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-03-25	Downgrade	Erste Group	Buy → Hold
Sep-08-25	Upgrade	Oppenheimer	Perform → Outperform	$125
Jun-16-25	Initiated	Leerink Partners	Outperform	$118
Apr-16-25	Upgrade	Needham	Hold → Buy	$113
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55

Show Previous Ratings

Today 08:32AM	Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now (Zacks)
08:05AM	Boston Scientific Sustains Momentum in the PFA Market: What's Next? (Zacks)
07:17AM	BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System (Zacks)
07:12AM	Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now (Zacks)
Dec-10-25 08:05AM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
11:47AM	Loading…
Dec-09-25 11:47AM	These 3 Stocks Are Healthcare Leaders. Bullish Charts Show It. (Barrons.com)
07:28AM	Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now (Zacks)
Dec-08-25 11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
10:27AM	CONMED Stock Falls as It Strategically Exits Gastroenterology Portfolio (Zacks)
09:40AM	Are Medical Stocks Lagging AtriCure (ATRC) This Year? (Zacks)
Dec-05-25 06:07PM	Boston Scientific Corporation (BSX): A Bull Case Theory (Insider Monkey)
11:47AM	GEHC Forms 7-Year Care Alliance to Advance URMC Imaging & Monitoring (Zacks)
Dec-04-25 11:43AM	IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge? (Zacks)
11:33AM	HealthEquity Stock Gains as Q3 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
11:30AM	GEHC and Mayo Clinic Launch GEMINI-RT to Aid Personalized Cancer Care (Zacks)
08:27AM	Loading…
08:27AM	Should You Hold STERIS Stock in Your Portfolio for Now? (Zacks)
Dec-03-25 12:43PM	TMO Stock Benefits From New Bioprocess Design Center in Asia (Zacks)
08:14AM	Should You Continue to Hold RMD Stock in Your Portfolio? (Zacks)
08:08AM	The US Rollout of MiniMed 780G With Abbott's Sensor May Lift MDT Stock (Zacks)
Dec-02-25 12:56PM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
12:49PM	GEHC Unveils Allia Moveo to Elevate Mobility in Interventional Care (Zacks)
08:26AM	Baxter Issues Recall Notice for Permanent Removal of Life2000 Ventilation (Zacks)
08:25AM	HSIC Stock Benefits From Expanded Partnership With vVARDIS (Zacks)
07:56AM	M&A Strategy Strengthens Boston Scientific's Growth Prospects (Zacks)
07:53AM	Should You Continue to Hold LH Stock in Your Portfolio? (Zacks)
Dec-01-25 11:47AM	GE HealthCare Unveils Next-Gen SIGNA MRI Systems to Elevate Efficiency (Zacks)
09:14AM	Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System (Zacks)
07:52AM	HSIC Stock Set to Benefit From Henry Schein One's Workflow Launch (Zacks)
Nov-28-25 12:44PM	Here's Why You Should Retain Glaukos Stock in Your Portfolio (Zacks)
09:50AM	Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term (Zacks)
09:30AM	Loading…
09:30AM	Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
06:59AM	Is Boston Scientific Stock Underperforming the Nasdaq? (Barchart)
Nov-26-25 01:00PM	EHC Expands in Tennessee Via New JV Facility With Vanderbilt Health (Zacks)
09:09AM	GEHC Stock Gains Post Latest Launch to Optimize Radiology Workflows (Zacks)
04:58AM	CMS covers cardiac ablation in ambulatory surgery centers (MedTech Dive)
Nov-25-25 09:45AM	Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term (Zacks)
08:22AM	Boston Scientific's Margins Strengthen in Q3: What's Driving It? (Zacks)
Nov-24-25 10:33PM	Q3 Earnings Roundup: Boston Scientific (NYSE:BSX) And The Rest Of The Medical Devices & Supplies - Diversified Segment (StockStory)
11:09AM	GE HealthCare to Acquire Intelerad for $2.3B to Boost Cloud Imaging (Zacks)
10:16AM	Okami raises $45M to commercialize vascular embolization devices (MedTech Dive)
08:25AM	BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now? (Zacks)
07:53AM	Should You Hold Quest Diagnostics Stock in Your Portfolio for Now? (Zacks)
Nov-21-25 12:00PM	Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know (Zacks)
11:30AM	Boston Scientific (BSX) Down 5.7% Since Last Earnings Report: Can It Rebound? (Zacks)
10:53AM	Veeva Systems Stock Down Despite Q3 Earnings & Revenues Top Estimates (Zacks)
10:50AM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
09:40AM	Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? (Zacks)
08:11AM	LH Shares Gain Following Publication of New Plasma Detect MRD Data (Zacks)
Nov-20-25 11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
09:34AM	Reasons to Add HealthEquity Stock to Your Portfolio for Now (Zacks)
07:49AM	TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner (Zacks)
Nov-19-25 07:25AM	BSX's Neuromodulation Prospect Looks Strong: What's Behind It? (Zacks)
Nov-18-25 04:08PM	Medtronic Breaks Out On Another 'Clean Beat' And 300% Growth For One Segment (Investor's Business Daily)
11:39AM	BFLY Stock Down Despite Launching Compass AI to Drive POCUS Programs (Zacks)
09:55AM	Wall Street Analysts Believe Boston Scientific (BSX) Could Rally 25.34%: Here's is How to Trade (Zacks)
09:31AM	Medtronic's Q2 Earnings & Revenues Beat Estimates, Stock Climbs (Zacks)
07:01AM	Medtronic Stock Rises After Earnings. What Caught Investors' Attention. (Barrons.com)
04:01AM	Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion (Zacks)
Nov-17-25 12:39PM	Ecolab Launches Integrated Cooling Platform to Support AI Data Centers (Zacks)
09:20AM	4 Medical Product Stocks to Watch From a Challenging Industry (Zacks)
07:40AM	Boston Scientific, Siemens Healthineers partner on cardiac catheter (MedTech Dive)
Nov-16-25 11:03PM	2 Reasons to Watch BSX and 1 to Stay Cautious (StockStory)
Nov-14-25 01:28PM	Boston Scientific gains US distribution duties for Siemens Healthineers ICE catheter (Medical Device Network)
08:02AM	HealthEquity Rolls Out Agentic AI to Elevate Member Support Experience (Zacks)
07:18AM	Boston Scientific Up 7% in a Month: How Should You Play the Stock? (Zacks)
Nov-13-25 11:20PM	UBS Boosts Boston Scientific (BSX) Price Target After Strong Q3 Earnings (Insider Monkey)
02:00PM	BDX Unveils Portable PureWick System for On-the-Go Incontinence Care (Zacks)
01:57PM	STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics (Zacks)
08:46AM	Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand (Zacks)
08:08AM	TFX Stock Falls Despite Q3 Earnings and Revenue Beat, '25 View Down (Zacks)
Nov-12-25 09:33AM	RGTI Stock Down Despite Q3 Earnings Top Estimates, Revenues Decline Y/Y (Zacks)
09:30AM	Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
07:13AM	ALC's Q3 Earnings Beat, Revenues Miss, Stock Rises in After-Market Hours (Zacks)
Nov-11-25 12:44PM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks)
09:30AM	Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet (Zacks)
08:30AM	If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now (Zacks)
07:55AM	Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand (Zacks)
07:26AM	VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up (Zacks)
Nov-10-25 12:45PM	Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
07:50AM	What's Behind Boston Scientific's Optimism for Urology Growth? (Zacks)
Nov-07-25 12:46PM	AMN Stock Gains Following Q3 Earnings & Revenue Beat, Margins Down (Zacks)
12:41PM	Doximity Stock Down Despite Q2 Earnings Beat, Revenues Up Y/Y (Zacks)
08:40AM	SOLV Gains on Q3 Earnings & Sales Beat, Raises '25 EPS Outlook (Zacks)
Nov-06-25 01:25PM	QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand (Zacks)
01:22PM	Inogen Stock Dips Despite Q3 Earnings Beat, Revenues Up Y/Y (Zacks)
01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks)
01:00PM	CONMED Q3 Earnings and Revenues Beat Estimates, Margins Contract (Zacks)
12:58PM	BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up (Zacks)
10:39AM	XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View (Zacks)
08:35AM	Avanos Medical Gains on Q3 Earnings Beat, Raises '25 Sales View (Zacks)
08:31AM	MCK Q2 Earnings Beat, Sales Miss, '26 EPS View Up, Stock Down (Zacks)
08:29AM	STE Stock Gains on Q2 Earnings and Revenue Beat, '26 EPS View Up (Zacks)
Nov-05-25 12:17PM	Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop (Zacks)
12:12PM	Hims & Hers Stock Slips Post Y/Y Q3 Earnings Decline, Margins Contract (Zacks)
12:09PM	MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand (Zacks)
11:01AM	TEM's Q3 Earnings & Revenues Beat, Stock Down in After-Market Hours (Zacks)
11:01AM	CLOV Q3 Earnings Miss, Stock Falls on Raised Insurance BER View (Zacks)
10:56AM	COR Q4 Earnings & Revenues Beat Estimates, Gross Margin Improves (Zacks)
10:53AM	FMS Stock Rises as Q3 Earnings Beat Estimates, Revenues Gain Y/Y (Zacks)
10:52AM	TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up (Zacks)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Dec 01 '25	Option Exercise	24.81	17,313	429,491	40,913	Dec 02 05:04 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Dec 01 '25	Sale	101.55	17,313	1,758,189	23,600	Dec 02 05:04 PM
ARTHUR C BUTCHER	Officer	Dec 01 '25	Proposed Sale	101.55	17,313	1,758,188		Dec 01 04:02 PM
Zane Ellen M	Director	Nov 06 '25	Sale	98.28	12,891	1,266,978	24,134	Nov 06 04:34 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Nov 03 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Nov 04 04:15 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Nov 03 '25	Sale	99.47	50,000	4,973,338	178,342	Nov 04 04:15 PM
JOSEPH M FITZGERALD	Officer	Nov 03 '25	Proposed Sale	99.47	50,000	4,973,335		Nov 03 04:05 PM
Zane Ellen M	Director	Oct 27 '25	Sale	101.13	9,990	1,010,301	27,035	Oct 28 05:44 PM
Zane Ellen M	Director	Oct 28 '25	Sale	102.24	2,901	296,599	24,134	Oct 28 05:44 PM
Zane Ellen M	Director	Oct 28 '25	Proposed Sale	102.24	2,901	296,592		Oct 28 10:55 AM
Zane Ellen M	Director	Oct 27 '25	Proposed Sale	100.91	9,990	1,008,081		Oct 27 10:50 AM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Oct 01 04:22 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Sale	98.47	50,000	4,923,327	178,342	Oct 01 04:22 PM
JOSEPH M FITZGERALD	Officer	Oct 01 '25	Proposed Sale	98.47	50,000	4,923,325		Oct 01 04:04 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Sep 03 04:17 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Sale	105.43	50,000	5,271,416	178,342	Sep 03 04:17 PM
JOSEPH M FITZGERALD	Officer	Sep 02 '25	Proposed Sale	105.43	50,000	5,271,415		Sep 02 04:08 PM
Monson Jonathan	EVP and CFO	Aug 02 '25	Option Exercise	0.00	1,090	0	35,817	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Sale	104.63	50,000	5,231,670	178,342	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Option Exercise	24.81	17,313	429,493	40,913	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Sale	104.63	17,313	1,811,520	23,600	Aug 04 05:43 PM
ARTHUR C BUTCHER	Officer	Aug 01 '25	Proposed Sale	104.63	17,313	1,811,519		Aug 01 04:03 PM
JOSEPH M FITZGERALD	Officer	Aug 01 '25	Proposed Sale	104.63	50,000	5,231,665		Aug 01 04:02 PM
FUJIMORI YOSHIAKI	Director	Jul 29 '25	Sale	106.99	2,901	310,378	2,081	Jul 30 04:06 PM
YOSHIAKI FUJIMORI	Director	Jul 29 '25	Proposed Sale	106.99	2,901	310,378		Jul 29 07:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Sale	106.03	4,000	424,120	18,479	Jul 28 04:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Proposed Sale	107.46	4,000	429,840		Jul 25 01:02 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Jul 02 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Sale	106.97	50,000	5,348,315	178,342	Jul 02 04:09 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jul 01 '25	Option Exercise	0.00	4,036	0	35,403	Jul 02 04:09 PM
JOSEPH M FITZGERALD	Officer	Jul 01 '25	Proposed Sale	106.97	50,000	5,348,310		Jul 01 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Option Exercise	26.15	56,372	1,474,128	234,714	Jun 04 07:44 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Sale	102.88	56,372	5,799,630	178,342	Jun 04 07:44 PM
JOSEPH M FITZGERALD	Officer	Jun 04 '25	Proposed Sale	102.88	56,372	5,799,625		Jun 04 04:02 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Option Exercise	20.67	105,619	2,183,161	1,641,325	Jun 03 04:47 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Sale	103.69	164,443	17,051,136	1,476,882	Jun 03 04:47 PM
MICHAEL F MAHONEY	Officer	Jun 02 '25	Proposed Sale	103.69	164,443	17,051,132		Jun 02 04:05 PM
LUDWIG EDWARD J	Director	May 29 '25	Sale	104.59	4,000	418,368	22,479	May 30 04:08 PM
LUDWIG EDWARD J	Director	May 29 '25	Proposed Sale	104.54	4,000	418,160		May 29 03:39 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '25	Sale	106.42	4,826	513,583	31,367	May 22 04:08 PM
VANCE BROWN	Officer	May 21 '25	Proposed Sale	106.42	4,826	513,583		May 21 04:09 PM
Sorenson John Bradley	EVP, Global Operations	May 02 '25	Option Exercise	0.00	4,204	0	25,195	May 06 04:37 PM
Sorenson John Bradley	EVP, Global Operations	May 05 '25	Sale	104.54	4,572	477,957	18,705	May 06 04:37 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02 '25	Option Exercise	0.00	2,102	0	24,337	May 06 04:36 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Option Exercise	20.67	105,619	2,183,161	1,700,149	May 05 05:16 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Sale	102.48	164,443	16,851,974	1,535,706	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Option Exercise	24.81	17,314	429,515	39,549	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Sale	102.06	17,314	1,766,982	22,235	May 05 05:16 PM
JOHN B SORENSON	Officer	May 05 '25	Proposed Sale	104.54	4,572	477,957		May 05 04:04 PM
MICHAEL F MAHONEY	Officer	May 01 '25	Proposed Sale	102.48	164,443	16,851,966		May 01 04:05 PM
ARTHUR C BUTCHER	Officer	May 01 '25	Proposed Sale	102.06	17,314	1,766,981		May 01 04:01 PM
Brown Vance R	SVP, GC and Corp. Secretary	Apr 21 '25	Sale	95.09	4,826	458,904	36,193	Apr 22 04:09 PM
VANCE BROWN	Officer	Apr 21 '25	Proposed Sale	95.09	4,826	458,904		Apr 21 04:01 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Option Exercise	20.67	105,618	2,183,144	1,758,972	Apr 02 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Sale	100.01	164,442	16,445,072	1,594,530	Apr 02 04:12 PM
MICHAEL F MAHONEY	Officer	Apr 01 '25	Proposed Sale	100.01	164,442	16,445,068		Apr 01 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	Mar 21 '25	Sale	100.85	4,826	486,702	41,019	Mar 24 04:26 PM
VANCE BROWN	Officer	Mar 21 '25	Proposed Sale	100.85	4,826	486,702		Mar 21 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Option Exercise	37.50	5,949	223,088	8,063	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Sale	104.97	7,149	750,465	914	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 04 '25	Sale	104.63	482	50,432	432	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Option Exercise	42.16	7,218	304,311	11,519	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 01 '25	Option Exercise	0.00	837	0	2,469	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Sale	101.13	9,887	999,872	1,632	Mar 03 04:11 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 24 '25	Sale	104.25	4,675	487,369	28,454	Feb 25 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 25 '25	Sale	104.00	2,688	279,552	25,766	Feb 25 04:41 PM
JEFFREY B MIRVISS	Officer	Feb 25 '25	Proposed Sale	104.00	2,688	279,552		Feb 25 04:02 PM
Zane Ellen M	Director	Feb 24 '25	Sale	104.23	13,586	1,416,134	34,944	Feb 24 04:08 PM
JEFFREY B MIRVISS	Officer	Feb 24 '25	Proposed Sale	104.25	4,675	487,369		Feb 24 04:01 PM
Zane Ellen M	Director	Feb 24 '25	Proposed Sale	104.23	13,586	1,416,088		Feb 24 11:30 AM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 14 '25	Option Exercise	0.00	661	0	3,867	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Option Exercise	0.00	2,115	0	27,609	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Sale	106.31	1,201	127,678	25,443	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	106	0	1,650	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	1,123	0	13,702	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 14 '25	Option Exercise	0.00	2,776	0	32,477	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '25	Option Exercise	0.00	18,334	0	1,662,219	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '25	Option Exercise	0.00	16,265	0	1,651,750	Feb 18 05:52 PM

Open in Screener

HOLX

Hologic, Inc

Dec 11 • 10:12AM ET

74.80

-0.03 -0.04 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: ABT BDX MDT QGEN ILMN BIO DGX A RMD

| Held by: VTI VOO VB VBR IVV SPY RSP XLV IHI IWR

Index	S&P 500	P/E	30.12	EPS (ttm)	2.48	Insider Own	1.62%	Shs Outstand	222.56M	Perf Week	-0.08%
Market Cap	16.67B	Forward P/E	14.95	EPS next Y	5.00	Insider Trans	-3.88%	Shs Float	219.29M	Perf Month	0.27%
Enterprise Value	17.10B	PEG	1.76	EPS next Q	1.09	Inst Own	98.94%	Short Float	1.97%	Perf Quarter	16.06%
Income	565.80M	P/S	4.07	EPS this Y	6.46%	Inst Trans	-1.30%	Short Ratio	1.32	Perf Half Y	14.69%
Sales	4.10B	P/B	3.30	EPS next Y	10.33%	ROA	6.23%	Short Interest	4.32M	Perf YTD	3.76%
Book/sh	22.68	P/C	7.57	EPS next 5Y	8.50%	ROE	11.12%	52W High	77.32 -3.26%	Perf Year	-1.31%
Cash/sh	9.88	P/FCF	18.12	EPS past 3/5Y	-21.45% -10.02%	ROIC	7.40%	52W Low	51.90 44.12%	Perf 3Y	0.78%
Dividend Est.	-	EV/EBITDA	13.58	Sales past 3/5Y	-5.53% 1.66%	Gross Margin	55.78%	Volatility	0.43% 0.37%	Perf 5Y	2.25%
Dividend TTM	-	EV/Sales	4.17	EPS Y/Y TTM	-25.29%	Oper. Margin	23.63%	ATR (14)	0.39	Perf 10Y	90.96%
Dividend Ex-Date	-	Quick Ratio	3.06	Sales Y/Y TTM	1.74%	Profit Margin	13.80%	RSI (14)	63.58	Recom	2.85
Dividend Gr. 3/5Y	- -	Current Ratio	3.75	EPS Q/Q	9.63%	SMA20	0.23%	Beta	0.70	Target Price	77.20
Payout	0.00%	Debt/Eq	0.52	Sales Q/Q	6.24%	SMA50	2.84%	Rel Volume	4.12	Prev Close	74.83
Employees	7070	LT Debt/Eq	0.51	Earnings	Nov 03 AMC	SMA200	14.22%	Avg Volume	3.27M	Price	74.80
IPO	Mar 01, 1990	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.89% 1.48%	Trades		Volume	2,048,885	Change	-0.04%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-21-25	Downgrade	BNP Paribas Exane	Outperform → Neutral	$79
Oct-07-25	Upgrade	Evercore ISI	In-line → Outperform	$78
Aug-18-25	Upgrade	Argus	Hold → Buy	$80
Aug-06-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$87
Jul-09-25	Upgrade	Citigroup	Neutral → Buy	$80
May-27-25	Reiterated	Needham	Hold
Mar-03-25	Downgrade	Argus	Buy → Hold
Feb-06-25	Downgrade	Leerink Partners	Outperform → Market Perform	$80 → $75
Feb-03-25	Downgrade	Needham	Buy → Hold
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-10-24	Reiterated	Needham	Buy	$90
Dec-10-24	Initiated	Jefferies	Hold	$85
Oct-01-24	Downgrade	Citigroup	Buy → Neutral	$95 → $85
Jun-27-24	Initiated	Stephens	Overweight	$87
Apr-03-24	Upgrade	Citigroup	Neutral → Buy	$80 → $95
Jul-14-23	Upgrade	Needham	Hold → Buy	$95
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$75
Oct-13-22	Initiated	Mizuho	Buy	$75
Jul-20-22	Initiated	UBS	Neutral	$73
Jul-20-22	Downgrade	BofA Securities	Buy → Neutral	$81 → $75

Show Previous Ratings

Dec-08-25 09:19AM	HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026? (Zacks)
Dec-07-25 11:37PM	1 Mooning Stock on Our Watchlist and 2 Facing Headwinds (StockStory)
Dec-06-25 01:25PM	US Loses Financing Edge as Asia Borrows in Euros: Credit Weekly (Bloomberg)
Dec-04-25 10:23AM	Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions (Zacks)
Dec-03-25 12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
11:30AM	Loading…
11:30AM	Why Is Hologic (HOLX) Up 1% Since Last Earnings Report? (Zacks)
Dec-02-25 08:10AM	New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration (Business Wire)
Dec-01-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-27-25 08:23AM	HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet? (Zacks)
Nov-26-25 09:40AM	Here's Why Hologic (HOLX) is a Strong Value Stock (Zacks)
08:18AM	New Clinical Evidence Bolsters Hologic's Breast Cancer Technologies (Zacks)
Nov-25-25 08:08AM	New Clinical Evidence on Hologics AI-Powered Mammography Solutions Will Be Unveiled at RSNA (Business Wire)
Nov-21-25 09:10AM	Here Are Fridays Top Wall Street Analysts Research Calls: Advanced Micro Devices, Block, Broadcom, Exact Sciences, Hologic, Palo Alto Networks and More (24/7 Wall St.)
07:13AM	Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It? (Zacks)
09:31AM	Loading…
Nov-20-25 09:31AM	US healthcare group Abbott bets on cancer screening technology in $23bn deal (Financial Times)
Nov-19-25 11:02PM	3 Reasons HOLX is Risky and 1 Stock to Buy Instead (StockStory)
Nov-18-25 09:29AM	Should You Continue to Hold Hologic Stock Post Q4 Earnings? (Zacks)
09:00AM	Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know (Zacks)
Nov-14-25 04:01PM	VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Revenue ... (GuruFocus.com)
03:19PM	Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Nov-13-25 08:49AM	Hologic Expands European Reach of Genius Digital Diagnostics System (Zacks)
Nov-12-25 09:50AM	Here's Why Hologic (HOLX) is a Strong Momentum Stock (Zacks)
08:11AM	Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking (Business Wire)
Nov-11-25 11:41AM	The transatlantic medtech investment gap: why does it exist and can it be plugged? (Medical Device Network)
Nov-10-25 09:40AM	Why Hologic (HOLX) is a Top Value Stock for the Long-Term (Zacks)
Nov-07-25 04:36PM	Halper Sadeh LLC Encourages IMXI, CMA, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
09:00AM	Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock (Zacks)
07:37AM	Hologic's Breast Health Rebounds, Takes Spotlight in Buyout Deal (Zacks)
Nov-04-25 08:07AM	HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands (Zacks)
06:45PM	Loading…
Nov-03-25 06:45PM	Analyst Report: Hologic, Inc. (Morningstar Research)
05:30PM	Hologic (HOLX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:15PM	Hologic (HOLX) Q4 Earnings and Revenues Beat Estimates (Zacks)
04:28PM	Hologic (NASDAQ:HOLX) Exceeds Q3 Expectations (StockStory)
04:22PM	Hologic: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025 (Business Wire)
Nov-01-25 11:06PM	Hologic (HOLX) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-30-25 12:25PM	Halper Sadeh LLC Encourages HOLX, FITB, HSII Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
09:06AM	HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment? (Zacks)
Oct-29-25 09:15AM	Gear Up for Hologic (HOLX) Q4 Earnings: Wall Street Estimates for Key Metrics (Zacks)
Oct-28-25 10:00AM	Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-27-25 10:00AM	Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:00AM	Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? (Zacks)
Oct-24-25 11:21AM	Analyst Report: Hologic, Inc. (Morningstar Research)
Oct-23-25 09:39AM	LendingClub upgraded, Enphase Energy downgraded: Wall Street's top analyst calls (The Fly)
Oct-22-25 05:28AM	Hologic set for $18.3bn takeover by Blackstone and TPG (Medical Device Network)
Oct-21-25 05:51PM	This Blackstone-TPG deal joins over $700 billion worth of private-equity buyouts this year. That's good news for shareholders. (MarketWatch)
04:54PM	Financial Services Roundup: Market Talk (The Wall Street Journal)
04:06PM	Hologic, After Spiking On Rumors, Agrees To $18.3 Billion Take-Private Deal (Investor's Business Daily)
01:41PM	Hologic (HOLX) Stock Is Up, What You Need To Know (StockStory)
11:40AM	HOLX or IDXX: Which Is the Better Value Stock Right Now? (Zacks)
10:45AM	Halliburton's profit plummets, Hologic to go private in $18.3B deal (Yahoo Finance Video)
10:38AM	Blackstone, TPG plan to take Hologic private in a deal worth more than $13 billion (Associated Press Finance)
09:18AM	Blackstone, TPG to Buy Hologic for Up to $18.3 Billion (The Wall Street Journal)
08:41AM	Hologic to be Acquired by Blackstone and TPG for up to $79 per Share (Business Wire)
08:30AM	Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market (PR Newswire)
06:54AM	Hologic to go private for up to $18.3B (MedTech Dive)
Oct-20-25 11:08AM	Billion-Dollar Buyout Buzz Boosts Medtech Stock (Schaeffer's Research)
08:45AM	Buy, Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings (Zacks)
07:55AM	Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks (Barrons.com)
Oct-16-25 05:45PM	Why the Market Dipped But Hologic (HOLX) Gained Today (Zacks)
06:10AM	What to Expect From Hologics Next Quarterly Earnings Report (Barchart)
Oct-14-25 09:00AM	Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now? (Zacks)
08:35AM	HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth (Zacks)
Oct-10-25 05:45PM	Hologic (HOLX) Stock Moves -1.25%: What You Should Know (Zacks)
Oct-08-25 08:20AM	Hologic Expands Panther Fusion's Menu With Diagnostic Innovation (Zacks)
12:02AM	3 Reasons HOLX is Risky and 1 Stock to Buy Instead (StockStory)
Oct-06-25 08:05AM	How to Play HOLX Stock This Breast Cancer Awareness Month? (Zacks)
Oct-03-25 08:21AM	HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests (Zacks)
Oct-02-25 05:45PM	Why Hologic (HOLX) Outpaced the Stock Market Today (Zacks)
04:04PM	Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025 (Business Wire)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
08:05AM	Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis (Business Wire)
Oct-01-25 11:40AM	HOLX vs. IDXX: Which Stock Is the Better Value Option? (Zacks)
09:10AM	Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum (Zacks)
Sep-30-25 09:50AM	Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term (Zacks)
09:30AM	QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test (Zacks)
09:00AM	Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Sep-29-25 09:30AM	Volition Signs Co-Marketing and Services Agreement with Hologic (PR Newswire)
09:30AM	Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan Insight FD Mini C-Arm (PR Newswire)
Sep-28-25 11:31PM	Medical Devices & Supplies - Imaging, Diagnostics Stocks Q2 Highlights: Hologic (NASDAQ:HOLX) (StockStory)
Sep-26-25 05:45PM	Why Hologic (HOLX) Outpaced the Stock Market Today (Zacks)
08:00AM	New Data on Hologics AI-Powered Mammography Technology to Be Presented at EUSOBI (Business Wire)
Sep-24-25 09:43AM	HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer? (Zacks)
Sep-22-25 11:38AM	Is Hologic Stock Underperforming the S&P 500? (Barchart)
09:24AM	HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today? (Zacks)
08:57AM	908 Devices (MASS) Surges 7.0%: Is This an Indication of Further Gains? (Zacks)
Sep-19-25 05:45PM	Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
09:00AM	Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Sep-18-25 10:47AM	Hologic (HOLX) Jumps 7.7% on Renewed Billion-Dollar Takeover Bid (Insider Monkey)
08:56AM	Hologic's Strong International Traction to Continue Despite Headwinds (Zacks)
08:40AM	Hologic (HOLX) Soars 7.7%: Is Further Upside Left in the Stock? (Zacks)
Sep-17-25 07:01PM	Review & Preview: The Fed Cuts, Wall Street Yawns (Barrons.com) +7.69%
04:48PM	Top Stock Reports for Exxon Mobil, AMD & Caterpillar (Zacks)
04:41PM	Blackstone and TPG revive interest in buying Hologic, source says (Reuters)
Sep-16-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Sep-15-25 09:00AM	Hologic's Breast Health Rebound in Motion: How to Play the Stock Now? (Zacks)
Sep-11-25 07:50AM	Does Hologic (HOLX) Have a Compelling Valuation? (Insider Monkey)
Sep-10-25 05:45PM	Hologic (HOLX) Stock Sinks As Market Gains: What You Should Know (Zacks)
10:06AM	Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds (Zacks)

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stamoulis Christiana	Director	Oct 20 '25	Option Exercise	36.04	7,402	266,768	54,738	Oct 22 04:17 PM
Stamoulis Christiana	Director	Oct 20 '25	Sale	73.07	7,402	540,864	47,336	Oct 22 04:17 PM
Stamoulis Christiana	Director	Oct 20 '25	Proposed Sale	73.07	7,402	540,864		Oct 20 10:12 AM
MACMILLAN STEPHEN P	Chairman, President and CEO	Sep 22 '25	Option Exercise	39.96	138,358	5,528,786	1,372,982	Sep 23 04:10 PM
MACMILLAN STEPHEN P	Chairman, President and CEO	Sep 22 '25	Sale	66.97	138,358	9,266,118	1,234,624	Sep 23 04:10 PM
MACMILLAN STEPHEN P	Officer	Sep 22 '25	Proposed Sale	66.98	138,358	9,266,548		Sep 22 04:25 PM
Madaus Martin D	Director	May 07 '25	Buy	55.24	5,445	300,760	5,445	May 09 04:39 PM

BSX

Boston Scientific Corp

HOLX

Hologic, Inc

Upgrade your FINVIZ experience